CTRI/2024/07/070014尚未招募2 期
An open label comparative study to evaluate the efficacy of Marma chikitsa and Agnikarma in the management of Avabahuka WSR to Frozen shoulder. - nil
Dr Aswathy K0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Patient fulfilling diagnostic criteria.
- •2)Patient irrespective of gender, religion, occupation,socioeconomic status etc will be included in the study.
- •3)Shoulder pain for at least 3 months and less than 12 months duration.
- •5)Patients with controlled diabetes mellitus and other systemic diseases such as hyperthyroidism and hypothyroidism.
- •6)Patients fit for agnikarma as per classics.
排除标准
- •1)Patients suffering from major trauma having dislocation or fracture of shoulder joint.
- •2)Patients of uncontrolled Diabetes mellitus.
- •3)Other diseases like Paralysis, Parkinson’s disease, cardiac diseases, renal diseases and endocrine diseases, severe Anemia, and Malignancy, tuberculosis
- •4)Pregnant and lactating female.
- •5)Patients contraindicated for Agnikarma as per classics.
- •6)Patients who need other emergency interventions like surgery.
- •7)Those patients who are regularly taking dependent on some specific medicines like anticoagulant, antiplatelet medicines, immunosuppressive medicines.
- •8)HIV and HbsAg reactive patients.
研究者
相似试验
已完成
不适用
An open-label comparative study to evaluate the effectiveness of video education during outpatient waiting time in chronic kidney diseasechronic kidney diseaseJPRN-UMIN000045882Chiba University Hospital50
已完成
3 期
Clinical trial on patients with menorrhagiaCTRI/2023/01/049258Jagdale industries pvt Ltd60
已完成
不适用
Open-labeled, comparative study to evaluate the efficacy and safety of KislipKCT0004917Kyung Hee University Hosipital at Gangdong40
尚未招募
2 期
Kushtadi churna and pippalyadi churna pratisarana in tundikeri vis-a-vis chronic tonsillitisCTRI/2024/05/067358Dr MD Shahid Musaib
进行中(未招募)
1 期
A Study of Xenical (Orlistat) in Overweight and Obese AdolescentsEUCTR2016-001661-91-Outside-EU/EEAF. Hoffmann-La Roche AG80
